Monday, August 31, 2026

Tenet Healthcare Stock Was 11.16% Up Today

ViaNews Editorial Team

November 18, 2023

Tenet Healthcare Stock Was 11.16% Up Today

(VIANEWS) - The NYSE ended the session with Tenet Healthcare rising 11.16% to $64.63 on Saturday, following the last session's downward trend. NYSE rose 0.59% to $15,809.74, following the last session's downward trend on what was a somewhat bullish trend trading session today.

Tenet Healthcare's last close was $58.14, 31.92% below its 52-week high of $85.40.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates through three segments: Hospital Operations, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Further, the company offers end-to-end and focused-point business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.

Earnings Per Share

As for profitability, Tenet Healthcare has a trailing twelve months EPS of $4.38.

PE Ratio

Tenet Healthcare has a trailing twelve months price to earnings ratio of 14.76. Meaning, the purchaser of the share is investing $14.76 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.15%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Tenet Healthcare's stock is considered to be oversold (<=20).

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Mar 12, 2000, the estimated forward annual dividend yield is 2.03%.

Yearly Top and Bottom Value

Tenet Healthcare's stock is valued at $64.63 at 02:04 EST, way below its 52-week high of $85.40 and way above its 52-week low of $40.39.

More news about Tenet Healthcare (THC).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com